Loading...
Loading...
CHEK| Name | Value |
|---|---|
| Revenues | 0.0K |
| Cost of Revenue | 95.0K |
| Gross Profit | -95.0K |
| Operating Expense | 6,063.0K |
| Operating I/L | -7,427.0K |
| Other Income/Expense | 549.0K |
| Interest Income | 549.0K |
| Pretax | -6,878.0K |
| Income Tax Expense | 815.0K |
| Net Income/Loss | -6,878.0K |
Check-Cap Ltd. is a clinical stage medical diagnostics company that develops a capsule-based screening technology using ultra-low-dose X-rays to scan the colon for precancerous polyps and structural abnormalities. Its C-Scan system includes the C-Scan Cap for polyp detection, C-Scan Track for data collection, and C-Scan View software for data analysis and report generation. The company generates revenue through the sale of its C-Scan system and related software, providing healthcare professionals with a non-invasive and patient-friendly solution for colon screening.
